| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.35B | 22.67B | 23.26B | 22.01B | 21.35B | 21.77B |
| Gross Profit | 26.35B | 21.19B | 20.91B | 20.35B | 20.90B | 21.21B |
| EBITDA | 2.40B | 3.76B | -3.37B | 2.57B | 4.69B | 4.60B |
| Net Income | 2.15B | 1.86B | -3.30B | 1.47B | 2.58B | 2.16B |
Balance Sheet | ||||||
| Total Assets | 1.80T | 1.81T | 1.76T | 1.89T | 1.81T | 1.80T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 243.10B | 165.70B | 248.75B | 186.75B | 216.19B |
| Total Debt | 106.67B | 118.03B | 133.95B | 126.69B | 295.63B | 206.91B |
| Total Liabilities | 1.73T | 1.73T | 1.68T | 1.81T | 1.73T | 1.71T |
| Stockholders Equity | 73.94B | 71.65B | 78.40B | 73.67B | 81.13B | 85.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | -6.70B | 57.40B | -1.07B | 140.68B |
| Operating Cash Flow | 0.00 | 0.00 | -6.26B | 58.32B | 77.00M | 141.15B |
| Investing Cash Flow | 0.00 | 4.74B | 61.00B | 4.83B | -28.35B | -20.73B |
| Financing Cash Flow | 0.00 | 51.92B | -81.21B | -797.00M | -719.00M | -661.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥39.55B | 24.09 | ― | 2.87% | 16.42% | 119.62% | |
72 Outperform | ¥23.88B | 7.08 | ― | 3.50% | 16.60% | -5.51% | |
68 Neutral | ¥39.20B | 10.62 | ― | 3.28% | 22.26% | -12.68% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥18.48B | 4.85 | ― | 3.37% | 3.70% | 24.98% | |
64 Neutral | ¥29.26B | 7.87 | ― | 2.59% | 4.90% | ― | |
64 Neutral | ¥15.77B | 4.33 | ― | 3.30% | 11.93% | 36.32% |